Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Envoy Medical (COCH) Amortizatization of Intangibles (2022 - 2023)

Envoy Medical's Amortizatization of Intangibles history spans 2 years, with the latest figure at $274633.0 for Q2 2023.

On a quarterly basis, Amortizatization of Intangibles rose 2208.34% to $274633.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $1.0 million, a N/A change, with the full-year FY2022 number at $704857.0, up 41.06% from a year prior.
Amortizatization of Intangibles hit $274633.0 in Q2 2023 for Envoy Medical, up from $234525.0 in the prior quarter.
Over the last five years, Amortizatization of Intangibles for COCH hit a ceiling of $520272.0 in Q4 2022 and a floor of -$13026.0 in Q2 2022.